Colette Parker
Neurology with Special Qualifications in Child Neurology · Jackson, MSNPI 1053357749
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 49.1% of the total. 2025 is the largest year on record at $6,209, 8.0 times the $780 reported in 2019.
Across 99 payments — averaging $87.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$4K
- Livanova USA, Inc.$2K
- UCB, Inc.$1K
- Jazz Pharmaceuticals Inc.$632
- Immedica Pharma US, Inc.$254
- Eisai Inc.$209
- plus $597 from 14 others
What the payments were for
- Speaking & faculty fees$3,50040%
- Travel & lodging$1,41016%
- Food & beverage$3,75343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 14 | $4,257 |
| Livanova USA, Inc. | 14 | $1,611 |
| UCB, Inc. | 22 | $1,104 |
| Jazz Pharmaceuticals Inc. | 8 | $632 |
| Immedica Pharma US, Inc. | 5 | $254 |
| Eisai Inc. | 8 | $209 |
| Greenwich Biosciences, Inc. | 4 | $101 |
| SK Life Science, Inc. | 3 | $95 |
| Piramal Critical Care | 3 | $69 |
| Supernus Pharmaceuticals, Inc. | 4 | $60 |
| Upsher-smith Laboratories LLC | 2 | $50 |
| Saol Therapeutics Inc. | 2 | $44 |
| PTC Therapeutics, Inc. | 2 | $39 |
| Catalyst Pharmaceuticals, Inc. | 2 | $27 |
| Neurelis, Inc. | 1 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| Orchard Therapeutics North America | 1 | $23 |
| Sanofi | 1 | $16 |
| NS Pharma, Inc. | 1 | $12 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAYBUE$4,124
- VNS Therapy$1,252
- Epidiolex$243
- Fintepla$213
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$151
- ZTALMY$149
- Vimpat$125
How this compares
Too few neurology with special qualifications in child neurology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 26 | $136,491 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $1,287 |
| Divalproex Sodium | 23 | $828 |
| Levocarnitine | 11 | $550 |
| AmantadineAmantadine Hcl | 11 | $433 |
| Risperidone | 11 | $308 |
| Zonisamide | 12 | $229 |
| Baclofen | 13 | $172 |
| Phenobarbital | 12 | $161 |
| Diazepam | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Jackson
- John IngramJackson$130K
- Ashley Stanley-CopelandJackson$10K
- Lamar DavisJackson$4K
- Ameze EroJackson$1K
- James ThompsonJackson$808
- Matthew McGuireJackson$750
- Marcus LeeOcean Springs$68K
- Vettaikorumakankav VedanarayananMadison$33K
- Richard GormanBiloxi$35
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.